Raben David bought BCAX
October 9, 2025 · Form 4 insider transaction
Raben David bought 22,000 shares of Bicara Therapeutics Inc. at $3.79 per share, a transaction worth $83.4K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
22,000
Price
$3.79
Total value
$83.4K
InsiderRaben David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateOctober 9, 2025
Filing dateOctober 10, 2025
Shares owned after57,497
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.